Hematox vs NCCN Reimbursement Resource

Hematox®, a bibliographical databank based on drug-induced blood disorders, was created in 1983 by Michel BIOUR (MD, PhD), and monthly updated in accordance with other bibliographical databases to the analysis of the references cited in the articles. All the published cases for selection and classification were re-evaluated in accordance with criterions usually validated in hematology. 1069 drugs are registered with 15126 corresponding and available references. Anticancer drugs and immunomodulators, well known for their intrinsic hematotoxicity, are not indexed in Hematox.

The oncology reimbursement landscape continues to present ever-evolving challenges for clinicians and others who work with patients with cancer. As a response to these ongoing challenges, help is available through the NCCN Reimbursement Resource App. Users can select a cancer or supportive care indication, search by drug name, or select a reimbursement or assistance program to learn about available reimbursement help and services to help mitigate reimbursement challenges.